Russell Investments Group
AUGX

Russell Investments Group’s Augmedix, Inc. Common Stock AUGX Stock Holding History

Russell Investments Group’s Portfolio AUGX Stock Details AUGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-664,306
Closed -$1.56M – 3843
2024
Q3 		$1.56M Buy
664,306
+14,988
+2% +$30.3K ﹤0.01% 1813
2024
Q2 		$571K Sell
649,318
-7,728
-1% -$15.9K ﹤0.01% 2153
2024
Q1 		$2.69M Sell
657,046
-234,031
-26% -$1.05M ﹤0.01% 1490
2023
Q4 		$5.21M Buy
891,077
+663,778
+292% +$3.49M 0.01% 1120
2023
Q3 		$1.17M Sell
227,299
-230,113
-50% -$1.08M ﹤0.01% 1838
2023
Q2 		$2.2M Sell
457,412
-1,159,616
-72% -$4.01M ﹤0.01% 1499
2023
Q1 		$2.81M Buy
1,617,028
+1,257,170
+349% +$2.05M 0.01% 1382
2022
Q4 		$561K Buy
359,858
+28,950
+9% +$36.9K ﹤0.01% 2238
2022
Q3 		$478K Buy
330,908
+1,073
+0.3% +$1.84K ﹤0.01% 2264
2022
Q2 		$592K Buy
+329,835
New +$764K ﹤0.01% 2204
2022
Q1 		– Sell
-358,818
Closed -$1.13M – 2972
2021
Q4 		$1.13M Buy
+358,818
New +$1.3M ﹤0.01% 2088

Russell Investments Group's AUGX Position: Q4 2024 in Review

Russell Investments Group sold out of Augmedix, Inc. Common Stock (AUGX) in Q4 2024, closing a stake of 664,306 shares — an estimated $1.56M sold.

Russell Investments Group first reported a position in AUGX in Q4 2021 and held it in 11 quarters. The position peaked at $5.21M in Q4 2023. 0 funds tracked by Wall St. Rank hold AUGX as of Q4 2024.

  • Russell Investments Group reported no remaining Augmedix, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • Russell Investments Group sold 664,306 Augmedix, Inc. Common Stock shares in Q4 2024, an estimated $1.56M.
  • Russell Investments Group first reported a position in Augmedix, Inc. Common Stock in Q4 2021 and held it in 11 quarters.
  • Russell Investments Group's Augmedix, Inc. Common Stock position peaked at $5.21M in Q4 2023.
  • 0 funds tracked by Wall St. Rank held Augmedix, Inc. Common Stock as of Q4 2024.

Based on Russell Investments Group's 13F filing for Q4 2024, filed 13 Feb 2025.